Anbio Biotechnology (NNNN) Payables (2023 - 2025)

Anbio Biotechnology (NNNN) posted quarterly Payables of $60.4 billion for Q2 2025, up 3713163.46% quarter-over-quarter from $1.6 million in Q4 2024.

Anbio Biotechnology (NNNN) Payables (2023 - 2025) Analysis & Trends

Anbio Biotechnology (NNNN) has reported Payables for 3 consecutive years, with $60.4 billion the latest figure, recorded in Q2 2025.

In Q2 2025, Payables changed N/A year-over-year to $60.4 billion; the TTM figure through Jun 2025 stood at $60.4 billion (changed N/A YoY), while the FY2024 annual figure was $1.6 million, up 96.49% from the prior year.
Payables improved to $60.4 billion in Q2 2025 per NNNN's latest filing, from $1.6 million in the prior quarter.
Across five years, Payables topped out at $60.4 billion in Q2 2025 and bottomed at $827151.0 in Q4 2023.
Historically, Payables has averaged $20.1 billion across 3 years, with a median of $1.6 million in 2024.
On a YoY basis, Payables climbed as much as 96.49% in 2024 and fell as far as 96.49% in 2024.
Anbio Biotechnology's Payables stood at $827151.0 in 2023, then surged by 96.49% to $1.6 million in 2024, then surged by 3713163.46% to $60.4 billion in 2025.
Business Quant data shows NNNN's Payables at $60.4 billion in Q2 2025, $1.6 million in Q4 2024, and $827151.0 in Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Payables (Qtr)
1	Intuitive Surgical	134.13 Bn	128.91 Bn	1.96 Bn	277.20 Mn
2	Becton Dickinson	52.76 Bn	51.90 Bn	2.32 Bn	6.11 Bn
3	Alcon	35.81 Bn	34.46 Bn	1.68 Bn	968.00 Mn
4	Resmed	33.72 Bn	32.25 Bn	861.22 Mn	568.87 Mn
5	Medline	29.38 Bn	26.70 Bn	2.22 Bn	1.04 Bn
6	West Pharmaceutical Services	25.00 Bn	24.57 Bn	329.20 Mn	252.70 Mn
7	Solventum	15.46 Bn	15.06 Bn	1.29 Bn	701.00 Mn
8	Cooper Companies	14.88 Bn	14.74 Bn	735.40 Mn	233.30 Mn
9	Baxter International	13.58 Bn	11.43 Bn	1.03 Bn	1.03 Bn
10	Anbio Biotechnology	301.77 Mn	289.87 Mn	-	-

Download Data